Keyphrases
Antiretroviral Therapy Initiation
100%
Bone Loss
33%
CD4+ T
50%
Cell Count
16%
Cell Recovery
33%
Change in Concentration
16%
Clinical Trials
16%
Combined Antiretroviral Therapy (cART)
100%
Data Protection
16%
Early Change
16%
Ethics Committees
16%
HIV Patients
100%
Manuscript Title
100%
Multiplex Immunoassay
16%
Nave
100%
Osteoprotegrin
33%
Protection Agency
16%
Receptor Activator of nuclear factor-B Ligand
16%
Soluble Receptor
16%
Medicine and Dentistry
Alternative Complement Pathway C3 C5 Convertase
12%
Antiretroviral Therapy
100%
Cell Count
12%
Clinical Trial
12%
Human Immunodeficiency Virus
100%
Immunoassay
12%
Medicine
12%
Nuclear Factor
12%
Osteoclast Differentiation Factor
100%
Osteolysis
25%
Receptor
12%
T-Helper Cell
37%
Biochemistry, Genetics and Molecular Biology
CD4
25%
CD4 Lymphocyte Count
12%
Clinical Trial
12%
Complement Factor B
12%
Eicosanoid Receptor
12%
Human Immunodeficiency Virus
100%
Immunoassay
12%
Osteolysis
25%
RANKL
100%
T Cell
25%
Immunology and Microbiology
Blood Plasma
12%
CD4 Lymphocyte Count
12%
Complement Factor B
12%
Human Immunodeficiency Virus
100%
Immunoassay
12%
Osteolysis
25%
RANKL
100%
T-Helper Cell
25%
Pharmacology, Toxicology and Pharmaceutical Science
Alternative Complement Pathway C3 C5 Convertase
12%
Clinical Trial
12%
HIV
100%
Immunoassay
12%
Nuclear Factor
12%
Osteoclast Differentiation Factor
100%
Receptor
12%